Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epirubicin, cisplatin plus ifosfamide versus standard chemotherapeutic regimens for advanced/unresectable primary thoracic sarcomas.
Rodriguez-Cid JR, Juarez-Vignon Whaley JJ, Sánchez-Domínguez G, Guzmán-Casta J, Carrasco-CaraChards S, Guzmán-Huesca J, Riera-Sala R, Sánchez-Ríos CP, Cruz-Zermeño M, Seidman-Sorsby A, de Jesús Rodríguez-Zea I, Alatorre-Alexander JA, Martínez-Barrera LM, Santillán-Doherty PJ, Godina-Flores A, Imaz-Olguin V, Sosa-Sánchez R, Green-Renner D. Rodriguez-Cid JR, et al. J Cancer Res Clin Oncol. 2023 Aug;149(9):5479-5491. doi: 10.1007/s00432-022-04454-8. Epub 2022 Dec 4. J Cancer Res Clin Oncol. 2023. PMID: 36463530
Expression of estrogen receptor beta (ERβ) and its prognostic value in pleural mesothelioma.
Rodríguez-Cid JR, García-Acevedo O, Benjamin-Contreras J, Bonilla-Molina D, Flores-Mariñelarena RR, Martínez-Barrera L, Alatorre-Alexander JA, Sanchez-Ríos CP, Flores-Soto MDR, Santillan-Doherty PJ, Peña-Mirabal ES. Rodríguez-Cid JR, et al. J Thorac Dis. 2019 Apr;11(4):1456-1464. doi: 10.21037/jtd.2019.03.38. J Thorac Dis. 2019. PMID: 31179088 Free PMC article.
[National Clinical Practice Guidelines for the management of non-small cell lung cancer in early, locally advanced and metastatic stages. Extended version].
Barrón-Barrón F, Guzmán-De Alba E, Alatorre-Alexander J, Aldaco-Sarvider F, Bautista-Aragón Y, Blake-Cerda M, Blanco-Vázquez YC, Campos-Gómez S, Corona-Cruz JF, Iñiguez-García MA, Lozano-Ruiz FJ, Maldonado-Magos F, de la Mata-Moya D, Martínez-Barrera LM, Ramos-Prudencio R, Rodríguez-Cid J, Rivera-Rivera S, Trejo-Rosales RR, Aguilar-Ortíz MR, Astudillo-de la Vega H, Barajas-Figueroa LJ, Barroso-Quiroga N, Blanco-Salazar A, Castillo-Ortega G, Domínguez-Parra LM, Enriquez-Aceves MI, Fernández-Orozco A, Figueroa-Morales MA, Green-Schneewiss L, González-Garay JA, González Ramírez-Benfield R, Guadarrama-Orozco A, Guerrero-Ixtlahuac J, Hernández-Barajas D, Hernández-Montes de Oca R, Kelly-García J, Lázaro-León M, Silva-Bravo F, Tellez-Becerra JL, Macedo-Pérez EO, Maza-Ramos G, Mayorga-Butrón JL, Montaño-Velázquez BB, Murillo-Medina K, Narváez-Fernández S, Ochoa-Carrillo FJ, Olivares-Beltrán G, Olivares-Torres C, Ponce de León-Castillo M, Ponce-Viveros MA, Rubio-Gutiérrez JE, Sáenz-Frías JA, Silva-Vivas JA, Santillán-Doherty P, Soto-Ávila JJ, Toledo-Buenrostro V, Vargas-Abrego B, Velasco-Hidalgo L, Zapata-Tarres MM, Quintero-Beuló G, Arrieta O. Barrón-Barrón F, et al. Salud Publica Mex. 2019 May-Jun;61(3):359-414. doi: 10.21149/9916. Salud Publica Mex. 2019. PMID: 31276353 Spanish.
Real-World Evidence: Multicenter Efficacy and Toxicity Analysis of Nintedanib With Docetaxel as Second-Line Treatment in Mexican Patients With Advanced Lung Adenocarcinoma.
Rodríguez-Cid JR, Campos-Gomez S, García-Montes V, Magallanes-Maciel M, Flores-Mariñelarena RR, Fernández-Garibay VM, González-Espinoza IR, Ceja-García JP, Cázarez-Price JC, Martínez-Barrera L, Barriguete-Parra L, Zuloaga-Fernandez CJ, Kuri-Exsome R, Suárez-García D, Gonzalez-Villanueva JI, Flores-Anaya N, Acevedo-Delgado JA, Astorga-Ramos AM, Gerson-Cwilich R, Villalobos-Prieto A, Rodríguez-Silva C, Noriega-Iriondo MF, Vázquez-Cortés L, Perales-Rodríguez E, Acosta-Espinoza A, Perez-Lozano Y, Capdeville-García D, Alatorre-Alexander JA. Rodríguez-Cid JR, et al. JCO Glob Oncol. 2020 Mar;6:462-470. doi: 10.1200/JGO.19.00330. JCO Glob Oncol. 2020. PMID: 32196388 Free PMC article.
Human skin biomarkers relationship to response to treatment with tyrosine kinase inhibitors in advanced EGFR-mutated lung adenocarcinoma.
Castañeda-Zárraga A, Rodríguez-Cid JR, Flores-Mariñelarena RR, Trinidad-Bibiano H, Martínez-Herrera JF, Sánchez-Ríos CP, Fernández-Garibay VM, Alatorre-Alexander JA, Martínez-Barrera L, Santillán-Doherty PJ, Vega-Memije ME. Castañeda-Zárraga A, et al. Thorac Cancer. 2020 Nov;11(11):3243-3251. doi: 10.1111/1759-7714.13657. Epub 2020 Oct 5. Thorac Cancer. 2020. PMID: 33015988 Free PMC article.
Prognostic factors for progression-free and overall survival in malignant pleural mesothelioma.
Guzmán-Casta J, Carrasco-CaraChards S, Guzmán-Huesca J, Sánchez-Ríos CP, Riera-Sala R, Martínez-Herrera JF, Peña-Mirabal ES, Bonilla-Molina D, Alatorre-Alexander JA, Martínez-Barrera LM, Rodríguez-Cid JR. Guzmán-Casta J, et al. Among authors: rodriguez cid jr. Thorac Cancer. 2021 Apr;12(7):1014-1022. doi: 10.1111/1759-7714.13814. Epub 2021 Mar 4. Thorac Cancer. 2021. PMID: 33660947 Free PMC article.
A comparative study of immunotherapy as second-line treatment and beyond in patients with advanced non-small-cell lung carcinoma.
Rodríguez-Cid JR, Chards SC, González-Espinoza IR, García-Montes V, Garibay-Díaz JC, Hernández-Flores O, Riera-Sala R, Gozalishvili-Boncheva A, Alatorre-Alexander JA, Martínez-Barrera LM, Sánchez-Ríos CP, Martinez-Camacho A, Martínez-Herrera JF, Guzmán-Casta J, Flores-Mariñelarena RR, Diaz-Rico J, Santillán-Doherty P. Rodríguez-Cid JR, et al. Lung Cancer Manag. 2021 Mar 11;10(3):LMT47. doi: 10.2217/lmt-2020-0027. eCollection 2021 Sep. Lung Cancer Manag. 2021. PMID: 34408789 Free PMC article.
Paraneoplastic Cerebellar Degeneration with Anti-CV2/CRMP5 Antibodies in Ovarian Cancer: Case Report and Review of the Literature.
Juárez-Vignon Whaley JJ, Carrera-Muiños A, Hernandez-Gutierrez KG, Rodriguez-Cid JR, Otero-Cerdeira ME, Garcia-Montes V. Juárez-Vignon Whaley JJ, et al. Among authors: rodriguez cid jr. Case Rep Oncol. 2021 Dec 20;14(3):1799-1805. doi: 10.1159/000519969. eCollection 2021 Sep-Dec. Case Rep Oncol. 2021. PMID: 35111012 Free PMC article.
Survival prognostic factors in unresectable/advanced primary thoracic sarcomas.
Rodriguez-Cid JR, Juarez-Vignon Whaley JJ, Sánchez-Domínguez G, Guzmán-Casta J, Carrasco-CaraChards S, Alatorre-Alexander JA, Martínez-Barrera LM, Sánchez-Rios CP, Flores-Mariñelarena RR, Seidman-Sorsby A, Cruz-Zermeño M, Rodríguez-Zea IJ, Santillan-Doherty PJ. Rodriguez-Cid JR, et al. J Thorac Dis. 2022 Sep;14(9):3376-3385. doi: 10.21037/jtd-22-472. J Thorac Dis. 2022. PMID: 36245612 Free PMC article.
31 results